Literature DB >> 11856431

Recovery of Candida dubliniensis from sputum of cystic fibrosis patients.

Heidrun Peltroche-Llacsahuanga1, Hiltrud Döhmen, Gerhard Haase.   

Abstract

Yeasts have been cultivated in a high percentage of sputum samples from patients with cystic fibrosis (CF). In cases of Candida dubliniensis a high recovery rate (15-25%) has so far only been reported from the oral cavity of HIV-infected persons. When studying sputum samples of patients suffering from cystic fibrosis (n = 54) we could repeatedly observe C. dubliniensis in 6 patients (11.1%) by using a complex isolation procedure involving the use of Staib agar. This revealed that the prevalence rate was significantly higher than the estimated overall prevalence for all non-HIV infected patients (0.8%) currently reported.

Entities:  

Mesh:

Year:  2002        PMID: 11856431

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  16 in total

Review 1.  Fungal Pathogens in CF Airways: Leave or Treat?

Authors:  A Singh; A Ralhan; C Schwarz; D Hartl; A Hector
Journal:  Mycopathologia       Date:  2017-08-02       Impact factor: 2.574

2.  Rapid identification of Candida species in oral rinse solutions by PCR.

Authors:  Giorgio Liguori; Angela Lucariello; Giuseppe Colella; Antonio De Luca; Paolo Marinelli
Journal:  J Clin Pathol       Date:  2007-09       Impact factor: 3.411

3.  Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes.

Authors:  K Oliveira; G Haase; C Kurtzman; J J Hyldig-Nielsen; H Stender
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles.

Authors:  Susan Rigby; Gary W Procop; Gerhard Haase; Deborah Wilson; Geraldine Hall; Cletus Kurtzman; Kenneth Oliveira; Sabina Von Oy; Jens J Hyldig-Nielsen; James Coull; Henrik Stender
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Impact of Cigarette Smoke Condensate on Adhesion-Related Traits and Hemolysin Production of Oral Candida dubliniensis Isolates.

Authors:  Arjuna Nishantha Bandara Ellepola; Zia Uddin Khan
Journal:  Mycopathologia       Date:  2019-12-02       Impact factor: 2.574

Review 6.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

7.  Microbiological screening of Irish patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles, and incidences of clinical signs of oral candidiasis without culture evidence.

Authors:  Brenda A McManus; Eleanor McGovern; Gary P Moran; Claire M Healy; June Nunn; Pádraig Fleming; Colm Costigan; Derek J Sullivan; David C Coleman
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

8.  Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements.

Authors:  Rolf Kramer; Annette Sauer-Heilborn; Tobias Welte; Carlos A Guzman; Wolf-Rainer Abraham; Manfred G Höfle
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

9.  Candida dubliniensis infections in a pediatric population: retrospective identification from clinical laboratory isolates of Candida albicans.

Authors:  Jean O Kim; Lucille Garofalo; Deborah Blecker-Shelly; Karin L McGowan
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Differentiation of Candida dubliniensis from Candida albicans on rosemary extract agar and oregano extract agar.

Authors:  Erico Silva de Loreto; Patrícia Pozzatti; Liliane Alves Scheid; Deise Santurio; Janio Morais Santurio; Sydney Hartz Alves
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.